Zydus Lifesciences Ltd.

NSE: ZYDUSLIFE | BSE: 532321 | ISIN: INE010B01027 | Industry: Pharmaceuticals
| Mid-range Performer
975.0000 -44.25 (-4.34%)
NSE Sep 26, 2025 15:52 PM
Volume: 2.6M
High volume today

975.00
-4.34%
Karvy
Cadila's revenues grew by 17% YoY to Rs21.6 bn during the quarter on the back of strong performance in US region. Operating margins improved to 20.4% compared to 15.8% in Q3FY14, higher than our estimates of 19.6%. Net Profit at Rs 2,819 mn grew by 51.7% YoY in Q3FY15 due to better gross margins and lower overheads.
Zydus Lifesciences Ltd. is trading above its 200 day SMA of 949.2
More from Zydus Lifesciences Ltd.
Recommended